Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

Anne Wajja; Beatrice Nassanga; Agnes Natukunda; Joel Serubanja; Josephine Tumusiime; Helen Akurut; Gloria Oduru; Jacent Nassuuna; Joyce Kabagenyi; Hazel Morrison; Hannah Scott; Rebecca Powell Doherty; Julia L. Marshall; Ingrid Cabrera Puig; Stephen Cose; Pontiano Kaleebu; TB042 Study Team

doi:https://doi.org/10.1016/S1473-3099(23)00758-2

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

Anne Wajja, Beatrice Nassanga, Agnes Natukunda, Joel Serubanja, Josephine Tumusiime, Helen Akurut, Gloria Oduru, Jacent Nassuuna, Joyce Kabagenyi, Hazel Morrison, Hannah Scott, Rebecca Powell Doherty, Julia L. Marshall, Ingrid Cabrera Puig, Stephen Cose, Pontiano Kaleebu, TB042 Study Team

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	e78-e79
Journal	The Lancet Infectious Diseases
Volume	24
Issue number	2
DOIs	https://doi.org/10.1016/S1473-3099(23)00758-2
Publication status	Published - 1 Feb 2024
Externally published	Yes

Access to Document

https://doi.org/10.1016/S1473-3099(23)00758-2

Cite this

Wajja, A., Nassanga, B., Natukunda, A., Serubanja, J., Tumusiime, J., Akurut, H., Oduru, G., Nassuuna, J., Kabagenyi, J., Morrison, H., Scott, H., Powell Doherty, R., Marshall, J. L., Cabrera Puig, I., Cose, S., Kaleebu, P., & TB042 Study Team (2024). Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control. The Lancet Infectious Diseases, 24(2), e78-e79. https://doi.org/10.1016/S1473-3099(23)00758-2

@article{963cdabddf03442ea8926b5ca6215780,

title = "Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control",

author = "Anne Wajja and Beatrice Nassanga and Agnes Natukunda and Joel Serubanja and Josephine Tumusiime and Helen Akurut and Gloria Oduru and Jacent Nassuuna and Joyce Kabagenyi and Hazel Morrison and Hannah Scott and {Powell Doherty}, Rebecca and Marshall, {Julia L.} and {Cabrera Puig}, Ingrid and Stephen Cose and Pontiano Kaleebu and {TB042 Study Team} and Webb, {Emily L.} and Iman Satti and Helen McShane and Elliott, {Alison M.}",

year = "2024",

month = feb,

day = "1",

doi = "https://doi.org/10.1016/S1473-3099(23)00758-2",

language = "English",

volume = "24",

pages = "e78--e79",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Lancet Publishing Group",

number = "2",

}

Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Powell Doherty, R, Marshall, JL, Cabrera Puig, I, Cose, S, Kaleebu, P & TB042 Study Team 2024, 'Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control', The Lancet Infectious Diseases, vol. 24, no. 2, pp. e78-e79. https://doi.org/10.1016/S1473-3099(23)00758-2

TY - JOUR

T1 - Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

AU - Wajja, Anne

AU - Nassanga, Beatrice

AU - Natukunda, Agnes

AU - Serubanja, Joel

AU - Tumusiime, Josephine

AU - Akurut, Helen

AU - Oduru, Gloria

AU - Nassuuna, Jacent

AU - Kabagenyi, Joyce

AU - Morrison, Hazel

AU - Scott, Hannah

AU - Powell Doherty, Rebecca

AU - Marshall, Julia L.

AU - Cabrera Puig, Ingrid

AU - Cose, Stephen

AU - Kaleebu, Pontiano

AU - TB042 Study Team

AU - Webb, Emily L.

AU - Satti, Iman

AU - McShane, Helen

AU - Elliott, Alison M.

PY - 2024/2/1

Y1 - 2024/2/1

UR - http://www.scopus.com/inward/record.url?scp=85182986070&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/S1473-3099(23)00758-2

DO - https://doi.org/10.1016/S1473-3099(23)00758-2

M3 - Comment/Letter to the editor

C2 - 38184003

SN - 1473-3099

VL - 24

SP - e78-e79

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 2

ER -

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

Access to Document

Other files and links

Cite this